Short-Term Efficacy and Safety Outcomes of Brolucizumab in the Real-Life Clinical Practice.

Front Pharmacol · 2021 · PMC8600267 · PMID 34803674

Europe PMC DOI

hedged sentence

0.0650

closest p · 1.3× alpha

0.0650

boldest claim

The sentences

did not reach statistical significancep = 0.065so close (0.05 < p ≤ 0.1)

The reduction magnitude of IRF and PED size was overall positive even though it did not reach statistical significance ( p = 0.065 and p = 0.811, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.